Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 143.26
0.944 %
$ 14.5 B
Market Cap
38.2
P/E
NBIX - NET INCOME
Net Income NBIX - Neurocrine Biosciences, Inc.
250 M
LAST VALUE
66.94%
2 YEAR CAGR
63.90%
5 YEAR CAGR
22.19%
10 YEAR CAGR